Beta-O2 Technologies
Implantable Bioreactor for Treating Type 1 Diabetes
StartupBeta-O2 Technologies is a Rosh Haayin-based startup in the Health Tech & Life Sciences sector, established in 2004. Implantable Bioreactor for Treating Type 1 Diabetes. The company has raised a total of $8.22M across 6 funding rounds, currently at the Mature stage. Key investors include Sherpa InnoVentures, Internet Research Institute (IRI), Aurum Ventures M.K.I, among 5 total investors. The company has 11-50 employees. Core technologies: Biologicals, Cells.
With $8.22M in total funding, Beta-O2 Technologies is a Mature-stage company operating in Health Tech & Life Sciences. The company follows a B2B business model. Product stage: Released. The company holds 1 patent.
- StageMature
- ProductReleased
- ModelB2B
- Employees11-50
- HQRosh Haayin
- DistrictCenter District
- Last Round$25K
- Sherpa InnoVentures
- Internet Research Institute (IRI)
- Aurum Ventures M.K.I
5 investors total
9 articles covered by sources including www.bioworld.com,
www.jpost.com,
www.diabetes.co.uk,
www.calcalistech.com,
www.globes.co.il.
What does Beta-O2 Technologies do?
Beta-O2 Technologies is a biomedical company developing a proprietary implantable bioreactor, the Air, for the treatment of patients with type 1 diabetes. The Air is a small medical device that is implanted in a minimally invasive procedure. The device, which contains islets of Langerhans, is intended to free patients from insulin injections and continuous monitoring of glucose levels. The device also reduces the risk of hypoglycemic episodes and other complications of the condition. Because the Air device contains living cells, the patient needs to refill the air in the device using a replenishing device, which includes a dedicated injector.
How much funding has Beta-O2 Technologies raised?
Beta-O2 Technologies has raised $8.22M in total funding across 6 rounds. The company is currently at the Mature stage. Key investors include Sherpa InnoVentures, Internet Research Institute (IRI), Aurum Ventures M.K.I.
What sector is Beta-O2 Technologies in?
Beta-O2 Technologies operates in Health Tech & Life Sciences, Pharma & Medical Biotechnology, Biomaterials & Tissue Engineering, Medical Devices, Medical Treatment & Therapeutics, with core technologies in Biologicals, Cells. Target customers: Healthcare & Life Sciences, Healthcare, Patients, Providers.
Where is Beta-O2 Technologies located?
Beta-O2 Technologies is based in Amal Street 11, Rosh Haayin, Israel, Center District.